Literature DB >> 23215867

Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.

Anne Durandy1, Tineke Cantaert, Sven Kracker, Eric Meffre.   

Abstract

Autoimmune manifestations are paradoxical and frequent complications of primary immunodeficiencies, including T and/or B cell defects. Among pure B cell defects, the Activation-induced cytidine Deaminase (AID)-deficiency, characterized by a complete lack of immunoglobulin class switch recombination and somatic hypermutation, is especially complicated by autoimmune disorders. We summarized in this review the different autoimmune and inflammatory manifestations present in 13 patients out of a cohort of 45 patients. Moreover, we also review the impact of AID mutations on B-cell tolerance and discuss hypotheses that may explain why central and peripheral B-cell tolerance was abnormal in the absence of functional AID. Hence, AID plays an essential role in controlling autoreactive B cells in humans and prevents the development of autoimmune syndromes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23215867      PMCID: PMC4077434          DOI: 10.3109/08916934.2012.750299

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  63 in total

1.  Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome.

Authors:  Masayuki Kuraoka; Dongmei Liao; Kaiyong Yang; Sallie D Allgood; Marc C Levesque; Garnett Kelsoe; Yoshihiro Ueda
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

2.  Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.

Authors:  Greta Meyers; Yen-Shing Ng; Jason M Bannock; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Sara S Kilic; Guzide Aksu; Marianne Debré; Frédéric Rieux-Laucat; Mary Ellen Conley; Charlotte Cunningham-Rundles; Anne Durandy; Eric Meffre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-23       Impact factor: 11.205

3.  Activation-induced cytidine deaminase mediates central tolerance in B cells.

Authors:  Masayuki Kuraoka; T Matt Holl; Dongmei Liao; Mandy Womble; Derek W Cain; Alexander E Reynolds; Garnett Kelsoe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-23       Impact factor: 11.205

4.  Reprogramming towards pluripotency requires AID-dependent DNA demethylation.

Authors:  Nidhi Bhutani; Jennifer J Brady; Mara Damian; Alessandra Sacco; Stéphane Y Corbel; Helen M Blau
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

5.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.

Authors:  Laurence Menard; David Saadoun; Isabelle Isnardi; Yen-Shing Ng; Greta Meyers; Christopher Massad; Christina Price; Clara Abraham; Roja Motaghedi; Jane H Buckner; Peter K Gregersen; Eric Meffre
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

6.  The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates.

Authors:  Uttiya Basu; Fei-Long Meng; Celia Keim; Veronika Grinstein; Evangelos Pefanis; Jennifer Eccleston; Tingting Zhang; Darienne Myers; Caitlyn R Wasserman; Duane R Wesemann; Kurt Januszyk; Richard I Gregory; Haiteng Deng; Christopher D Lima; Frederick W Alt
Journal:  Cell       Date:  2011-01-20       Impact factor: 41.582

7.  Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity.

Authors:  Wenzhong Guo; Diana Smith; Katja Aviszus; Thiago Detanico; Ryan A Heiser; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

8.  The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence.

Authors:  Roland Geisberger; Cristina Rada; Michael S Neuberger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

9.  Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency.

Authors:  Christian Popp; Wendy Dean; Suhua Feng; Shawn J Cokus; Simon Andrews; Matteo Pellegrini; Steven E Jacobsen; Wolf Reik
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

10.  Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.

Authors:  Hong Zan; Jinsong Zhang; Sona Ardeshna; Zhenming Xu; Seok-Rae Park; Paolo Casali
Journal:  Autoimmunity       Date:  2009-02       Impact factor: 2.815

View more
  9 in total

Review 1.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

2.  Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.

Authors:  Tineke Cantaert; Jean-Nicolas Schickel; Jason M Bannock; Yen-Shing Ng; Christopher Massad; Fabien R Delmotte; Natsuko Yamakawa; Salome Glauzy; Nicolas Chamberlain; Tuure Kinnunen; Laurence Menard; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Julie Bruneau; Waleed Al-Herz; Sara Sebnem Kilic; Hans D Ochs; Charlotte Cunningham-Rundles; Mirjam van der Burg; Taco W Kuijpers; Sven Kracker; Hideo Kaneko; Yujin Sekinaka; Shigeaki Nonoyama; Anne Durandy; Eric Meffre
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

3.  Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID.

Authors:  Marcel Kuhny; Lisa R Forbes; Elif Çakan; Andrea Vega-Loza; Valentyna Kostiuk; Ravi K Dinesh; Salomé Glauzy; Asbjorg Stray-Pedersen; Ashley E Pezzi; I Celine Hanson; Alexander Vargas-Hernandez; Mina LuQuing Xu; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Ivan K Chinn; David G Schatz; Jordan S Orange; Eric Meffre
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 4.  Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?

Authors:  Ricardo García-Muñoz; Luis Llorente
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

5.  Cell Cycle Regulates Nuclear Stability of AID and Determines the Cellular Response to AID.

Authors:  Quy Le; Nancy Maizels
Journal:  PLoS Genet       Date:  2015-09-10       Impact factor: 5.917

6.  Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.

Authors:  Maria Pia Cicalese; Jolanda Gerosa; Manuela Baronio; Davide Montin; Francesco Licciardi; Annarosa Soresina; Rosa Maria Dellepiane; Maurizio Miano; Lucia Augusta Baselli; Stefano Volpi; Carlo Dufour; Alessandro Plebani; Alessandro Aiuti; Vassilios Lougaris; Georgia Fousteri
Journal:  Front Immunol       Date:  2018-08-06       Impact factor: 7.561

Review 7.  Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.

Authors:  Rekha D Jhamnani; Cristiane J Nunes-Santos; Jenna Bergerson; Sergio D Rosenzweig
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

8.  Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells.

Authors:  Franziska Auer; Deborah Ingenhag; Stefan Pinkert; Sven Kracker; Salima Hacein-Bey-Abina; Marina Cavazzana; Michael Gombert; Alberto Martin-Lorenzo; Min-Hui Lin; Carolina Vicente-Dueñas; Isidro Sánchez-García; Arndt Borkhardt; Julia Hauer
Journal:  Oncotarget       Date:  2017-09-07

Review 9.  Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.

Authors:  Georgios Sogkas; Faranaz Atschekzei; Ignatius Ryan Adriawan; Natalia Dubrowinskaja; Torsten Witte; Reinhold Ernst Schmidt
Journal:  Cell Mol Immunol       Date:  2021-04-01       Impact factor: 11.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.